Buprenorphine: Drug Safety Communication
FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
An article published in the July issue of The Journal of the American Dental Association (https://doi.org/10.1016/j.
Dentists are urged to be aware of their patients’ medication regimens, including buprenorphine, as it can impact dental treatment outcomes. Understanding the potential interactions between buprenorphine and other medications commonly used in dental care is crucial to avoid complications and ensure patient safety.
Collaboration between dentists and other healthcare providers, such as primary care physicians and addiction specialists, is emphasized as essential for providing holistic care to patients on buprenorphine. This collaborative approach helps in addressing the complex needs of individuals in recovery from opioid addiction, ensuring they receive comprehensive medical and dental care.
The American Dental Association (ADA) advocates for education and training initiatives to equip dentists with the knowledge and skills necessary to effectively manage patients’ dental care using buprenorphine. This includes understanding the unique challenges and considerations involved in treating this patient population, such as managing pain, addressing dental anxiety, and maintaining oral health.
Overall, the article underscores the importance of dentists being proactive and informed about the care of patients using buprenorphine, contributing to their overall health and well-being as part of a multidisciplinary healthcare team.
